Jideytro is FDA-approved for adult patients with locally advanced or metastatic ROS1-positive NSCLC who received prior ROS1 TKI therapy.
Cherry angiomas (CAs), also known as Campbell de Morgan spots, are common, benign, well-demarcated cutaneous vascular ...
In the CALIBRATE trial, 76% of encaleret-treated patients normalized both blood and urine calcium at week 24 vs 4% on standard of care, while 91% achieved intact PTH restoration.
Cancer progression within 36 months of combination therapy identified patients with overall survival of less than 2 years.
Delaying JAK inhibitor initiation yielded higher early antibody responses; earlier initiation linked to earlier improvement in arthritis.
Benefits include improvements for resilience and prosocial behavior, but not symptoms of anxiety or depression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results